Articles

Better Sooner: when software eats science, precision medicine is born

Marc Andreessen famously said, “software is eating the world.” Many nowadays say that AI eats the software. What about clinical science and precision medicine? We're all so familiar with our phones, and there's so much technology in there...
October 14, 2022 By Veronika Litinski

Votre génétique détermine l’efficacité du Tecta pour vous

Tecta (pantoprazole) est prescrit comme traitement pour les ulcères gastro-intestinaux ou pour le Reflux gastro-oesophagien, ce qui inclut les brûlures d’estomac, les reflux acides et l’oesophagite par reflux. Tecta appartient à une famille de drogues nommée Inhibiteurs de...
October 03, 2022 By Ruslan Dorfman

Why don’t painkillers work for everyone? A guide to pharmacogenetics-based chronic pain treatment

Chronic pain is notoriously hard to treat. Affected individuals endure pain for months or years, trying desperately to find a remedy to take the pain away. Unfortunately, less than 30% of patients respond, even with the best treatment....
September 29, 2022 By Ruslan Dorfman

Another CAMH clinical trial demonstrates the clinical benefits of pharmacogenetics for severe depression

Pharmacogenetics (PGx) assesses how each person metabolizes medications based on their DNA. For example, different people given the same dosage of an antidepressant may have quite different levels of the drug in their blood - some may not...
August 08, 2022 By Ruslan Dorfman

Pharmacogenetic testing for biologic medications? Myth vs reality

The escalating cost of biologic medications has private and public plan sponsors concerned. As a result, many are turning to new technologies to stratify patient populations with the aim of reducing the total cost of biologics. For example,...
June 20, 2022 By Ruslan Dorfman

Pillcheck: Optimizing Medication Plans for Seniors with Dementia

Centre for Aging + Brain Health Innovation (CABHI) study finds that Pillcheck helped identify medications that were not effective or posed a high risk of side effects for long-term care residents. The revised medication plans significantly improved the...
January 19, 2022 By Ruslan Dorfman

Douleurs articulaires ? Les meilleurs médicaments pour vous soulager sont...

Toutes les personnes souffrant d'arthrose et d'arthrite savent que ces pathologies peuvent gravement affecter leur capacité à mener une vie active normale. Elles se caractérisent par des articulations raides et enflées ainsi que par une douleur intense et...
December 23, 2021 By Ruslan Dorfman

Les statines sont-elles sans danger ? Cela dépend de votre génétique !

Lorsqu'il s'agit de contrôler le cholestérol, la première ligne de défense est toujours un mode de vie sain et un régime alimentaire équilibré. Mais lorsque cela ne suffit pas, les médicaments contre le cholestérol ont leur rôle à...
December 22, 2021 By Ruslan Dorfman

Precision medicine: a pragmatic addition to your DEI strategy

A recent study found that nearly 75% of employees in underrepresented groups — women, racial and ethnic minorities, and LGBTQ employees — do not feel they've personally benefited from their companies' diversity, equity and inclusion (DEI) programs. As many executives...
December 10, 2021 By Veronika Litinski

Les tests pharmacogénomiques à la rencontre de la psychiatrie

La médecine de précision, qui utilise les tests pharmacogénomiques, permet de standardiser le processus de recherche du traitement antidépresseur adapté à chaque patient, afin d’obtenir les meilleurs résultats possibles. La pharmacogénomique, également appelée pharmacogénétique ou PGx, favorise une...
November 23, 2021 By Ruslan Dorfman

Améliorer le traitement du TSPT à l'aide de la pharmacogénétique

Traduit par Jie Mei, étudiante en pharmacie. Révisé par Alison Wong, pharmacienne. Le trouble de stress post-traumatique (TSPT) est un trouble de santé mentale caractérisé par la reviviscence des événements traumatiques passée à travers des cauchemars et des...
October 30, 2021 By Ruslan Dorfman

TECTA: use of proton pump inhibitors can increase the risk of COVID-19 infection

A recent study  pre-published by the American Journal of Gastroenterology has identified a connection between the use of Proton Pump Inhibitors (PPIs) and the risk of COVID-19 infections. The risk of contracting the infection appears to increase with the PPI...
October 30, 2021 By Gouri Mukerjee

Pain and depression drugs not working? Antidepressants can interfere with opioids

Pharmacists have been long aware of the risks of combining certain pain and depression drugs. Many common antidepressants can significantly reduce the pain relief of opioid painkillers. A recent large-scale study of people who were taking antidepressants and...
October 30, 2021 By Ruslan Dorfman

Leveraging PGx to raise your value proposition in group benefits

If you’ve seen the movie Wall Street, you’ll remember the part when Charlie Sheen confronts the gregarious Wall Street money machine Gordon Gekko (Michael Douglas). Douglas glares at Sheen and says, “OK, pal, tell me something I don’t...
September 24, 2021 By Gil McGowan

Quelle est la précision des tests pharmacogénétiques ?

La pharmacogénétique utilise le profil génétique d'un patient pour prédire avec précision l'efficacité d'un médicament, guider le choix du dosage adéquat et améliorer la sécurité des traitements. Selon votre profil génétique, certains médicaments peuvent agir plus ou moins...
September 22, 2021 By Veronika Litinski

GeneYouIn et la Canada Vie élargissent l’accès aux tests pharmacogénétiques

Les tarifs préférentiels de Pillcheck sont maintenant offerts à tous les clients de l’assurance maladie de Canada Vie Toronto (Ontario), le 7 janvier 2020. – GeneYouIn Inc, un leader en médecine personnalisée, a annoncé aujourd’hui qu’il renforce sa...
September 22, 2021 By Veronika Litinski

Do Genetic Tests Belong in Benefit Plans?

Genetic tests can provide predictive insights into many domains, such as ancestry, inherited predisposition to disease or your body’s ability to respond to a certain medication treatment – pharmacogenetics. Veronika Litinski, Pillcheck’s CEO, discusses the benefits for plans...
September 22, 2021 By Veronika Litinski

Pharmacogenetic Testing May Improve Drug Treatments and Shorten Disability

This article in Benefits Quarterly for first quarter 2017 describes how methods of personalized medicine — specifically, pharmacogenetic (PGx) testing— can benefit private health plans, benefits managers, care providers and consumers alike. The authors cover pharmacogenomics as a...
September 22, 2021 By Veronika Litinski

Pillcheck PGx launches new program for benefits advisors on the heels of positive study results in the mental health area

The new program builds on the successful introduction of Pillcheck pharmacogenetics by many insurers seeking to impact the frequency and duration of Short-Term and Long-Term disability claims. Now the same rigorously evaluated, secure service is available to plans...
September 22, 2021 By Veronika Litinski

Le rôle de la pharmacogénétique pour les promoteurs de régime d’assurance

La manière dont la COVID accélère l’évolution des services d’assurance maladie et le rôle des services pharmacogénétiques (PGx). La PGx aide les adhérents des régimes d’assurance à obtenir les médicaments qui conviennent le mieux à leur rétablissement, et...
September 22, 2021 By Veronika Litinski